Singapore a top draw for Pfizer as it looks to invest for the long run

Quick Summary:

SINGAPORE: Singapore is not a low-cost manufacturing base, but good infrastructure, respect for intellectual property, access to talent, and a government with a vision are what makes it the go-to destination for US pharma giant Pfizer.

The API produced here is then exported to Pfizer plants across the world that make injectable drugs or oral pills.

The plant will produce active pharmaceutical ingredients (API) – the biologically active component of a drug – for Pfizer’s cancer, pain and antibiotic medicines.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: EconomyBusiness

Markets: MalaysiaSingapore

Topics: Singapore World Produced Plant Manufacturing Time Government Supply Global Mcdermott Pfizer

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-06 @ 07:00:00 (7 hours ago)

News Timezone: GMT +8:00

News Source URL: thestar.com.my

Language: English

Article Length: 543 words

Reading Time: 4 minutes read

Sentences: 18 lines

Sentence Length: 31 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © The Star

News ID: 21946030

View Article Analysis

About The Star

Main Topics: EconomyBusiness

Official Website: thestar.com.my

Update Frequency: 81 posts per day

Year Established: 1971

Headquarters: Malaysia

News Last Updated: 45 minutes ago

Coverage Areas: Malaysia

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #22

Publisher Details

Frequently Asked Questions